{"id":"https://openalex.org/W2939826708","doi":"https://doi.org/10.1136/lupus-2019-lsm.98","title":"98 Results of a phase 2, double-blind, randomized, placebo-controlled study of a reversible B cell inhibitor, XmAb\u00ae5871, in systemic lupus erythematosus (SLE)","display_name":"98 Results of a phase 2, double-blind, randomized, placebo-controlled study of a reversible B cell inhibitor, XmAb\u00ae5871, in systemic lupus erythematosus (SLE)","publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2939826708","doi":"https://doi.org/10.1136/lupus-2019-lsm.98","mag":"2939826708"},"language":"en","primary_location":{"id":"doi:10.1136/lupus-2019-lsm.98","doi":"https://doi.org/10.1136/lupus-2019-lsm.98","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2019-lsm.98","pdf_url":"https://lupus.bmj.com/content/lupusscimed/6/Suppl_1/A73.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://lupus.bmj.com/content/lupusscimed/6/Suppl_1/A73.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052053321","display_name":"Joan T. Merrill","orcid":"https://orcid.org/0000-0002-4514-2382","observed_orcids":["https://orcid.org/0000-0002-4514-2382","https://orcid.org/0000-0002-9205-940X"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan T Merrill","raw_affiliation_strings":["Oklahoma Medical Research Foundation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oklahoma Medical Research Foundation","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010955460","display_name":"Joshua June","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua June","raw_affiliation_strings":["Joshua June, DO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joshua June, DO","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045528523","display_name":"Fotios Koumpouras","orcid":"https://orcid.org/0000-0002-4530-7626","observed_orcids":["https://orcid.org/0000-0002-4530-7626"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fotios Koumpouras","raw_affiliation_strings":["Yale Univeristy School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Univeristy School of Medicine","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014022500","display_name":"Wambui Machua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801405887","display_name":"Piedmont Atlanta Hospital","ror":"https://ror.org/0008s4w86","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801405887","https://openalex.org/I4210153954"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wambui Machua","raw_affiliation_strings":["Piedmont Atlanta Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Piedmont Atlanta Hospital","institution_ids":["https://openalex.org/I2801405887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085307521","display_name":"Mohammed Faisal Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Faisal Khan","raw_affiliation_strings":["Arthritis and Rheumatology Center of Oklahoma, PLLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arthritis and Rheumatology Center of Oklahoma, PLLC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084645574","display_name":"Anca Askanase","orcid":"https://orcid.org/0000-0003-4597-5023","observed_orcids":["https://orcid.org/0000-0003-4597-5023"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anca D Askanase","raw_affiliation_strings":["Columbia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069066471","display_name":"Saira Zafar Sheikh","orcid":"https://orcid.org/0000-0003-4128-0443","observed_orcids":["https://orcid.org/0000-0003-4128-0443"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saira Z Sheikh","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089071991","display_name":"Arezou Khosroshahi","orcid":"https://orcid.org/0000-0001-8365-8497","observed_orcids":["https://orcid.org/0000-0001-8365-8497"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arezou Khosroshahi","raw_affiliation_strings":["Emory University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul Foster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133987","display_name":"Xencor (United States)","ror":"https://ror.org/03v2jew50","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Foster","raw_affiliation_strings":["Xencor Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xencor Inc","institution_ids":["https://openalex.org/I4210133987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104147430","display_name":"Debra Jeske Zack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133987","display_name":"Xencor (United States)","ror":"https://ror.org/03v2jew50","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra J Zack","raw_affiliation_strings":["Xencor Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xencor Inc","institution_ids":["https://openalex.org/I4210133987"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1950,"currency":"GBP","value_usd":2391},"apc_paid":{"value":1950,"currency":"GBP","value_usd":2391},"fwci":null,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A73","last_page":"A74"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-cd19-antibody","display_name":"anti-CD19","score":0.8330000042915344},{"id":"https://openalex.org/keywords/fc-engineered-antibody","display_name":"Fc-engineered antibody","score":0.765999972820282},{"id":"https://openalex.org/keywords/fc-gamma-receptor-iib","display_name":"Fc gamma receptor IIb","score":0.7229999899864197},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.8059999942779541},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9879999756813049},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.6439999938011169},{"id":"https://openalex.org/keywords/sledai","display_name":"SLEDAI","score":0.6140000224113464},{"id":"https://openalex.org/keywords/bilag","display_name":"BILAG","score":0.890999972820282},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.675000011920929},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9323583841323853},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7472971081733704},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.7384598851203918},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6274356842041016},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5719678401947021},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5545399785041809},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.5057175159454346},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.5005247592926025},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4932801127433777},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.4734988808631897},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.41242754459381104},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3983575403690338},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36370140314102173},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.2238752841949463},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.17838308215141296},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09401392936706543},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/lupus-2019-lsm.98","doi":"https://doi.org/10.1136/lupus-2019-lsm.98","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2019-lsm.98","pdf_url":"https://lupus.bmj.com/content/lupusscimed/6/Suppl_1/A73.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/lupus-2019-lsm.98","doi":"https://doi.org/10.1136/lupus-2019-lsm.98","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2019-lsm.98","pdf_url":"https://lupus.bmj.com/content/lupusscimed/6/Suppl_1/A73.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2939826708.pdf","grobid_xml":"https://content.openalex.org/works/W2939826708.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2952204111","https://openalex.org/W2414418896","https://openalex.org/W2136149088","https://openalex.org/W2794254410","https://openalex.org/W1920228500","https://openalex.org/W2108646369","https://openalex.org/W2131457901","https://openalex.org/W2550125338","https://openalex.org/W2140433336","https://openalex.org/W2141028706"],"abstract_inverted_index":{"Background":[0],"XmAb5871":[1,88,218,256,346],"is":[2],"a":[3,45,49,159],"humanized":[4],"anti-CD19":[5],"antibody":[6],"Fc-engineered":[7],"for":[8,166,243,257],"increased":[9],"affinity":[10],"to":[11,23,34,41,86,156,265,270,328,339],"FcgammaRIIb.":[12],"Co-ligation":[13],"of":[14,44,69,104,128,136,185,195,345],"CD19":[15],"and":[16,38,62,320],"FcgammaRIIb":[17],"inhibits":[18],"B":[19],"lineage":[20],"cells":[21],"key":[22],"lupus":[24],"pathogenesis.":[25],"This":[26,351],"Phase":[27],"2":[28,255],"study":[29,352],"in":[30,48,143,208,275,288,308,313,347],"SLE":[31,330],"was":[32,133,272,325,353],"designed":[33,338],"minimize":[35],"background":[36],"medications":[37],"placebo":[39,197,223,252,261,279,315],"responses":[40],"improve":[42],"interpretation":[43],"small":[46,336],"trial":[47],"complex,":[50],"heterogenous":[51],"disease.":[52],"Methods":[53],"Patients":[54,163],"were":[55,74,95,169,177,241,291,305],"enrolled":[56],"with":[57,66,119,200,214,228],"active,":[58],"non-organ":[59],"threatening":[60],"disease,":[61],"treated":[63],"until":[64,99],"improved":[65],"160":[67],"mg":[68],"IM":[70],"Depo-Medrol.":[71],"Immunosuppressive":[72],"drugs":[73],"withdrawn":[75,242],"except":[76],"antimalarials":[77],"or":[78,82,91,102,117,153,158,301],"10":[79,251],"mg/day":[80],"prednisone":[81],"equivalent":[83],"before":[84],"randomization":[85],"IV":[87],"(5":[89],"mg/kg)":[90],"placebo.":[92],"Study":[93],"treatments":[94],"given":[96],"Q14":[97],"days":[98],"Day":[100,141,151,189],"225":[101,142,152,190],"loss":[103],"improvement":[105],"(LOI),":[106],"defined":[107],"as":[108],"SLEDAI":[109,225],"increase":[110,226],"4":[111,314],"points":[112],"OR":[113],"new":[114],"BILAG":[115,235],"A":[116,236],"B,":[118],"investigator-rated":[120],"clinical":[121],"significance.":[122],"At":[123],"LOI,":[124,215],"patients":[125,176,219,240,253,277,290],"resumed":[126],"standard":[127],"care.":[129],"The":[130,246,284],"primary":[131],"endpoint":[132,207],"the":[134,144,180,196,209,266,298],"proportion":[135],"subjects":[137,187],"without":[138,191],"LOI":[139,157,192,271],"by":[140,355],"efficacy":[145,181,247],"evaluable":[146,182,248],"group":[147,198],"(those":[148],"who":[149,164],"completed":[150],"discontinued":[154],"due":[155],"drug-related":[160],"adverse":[161],"event).":[162],"withdrew":[165],"other":[167,258,329],"reasons":[168],"excluded":[170,250],"from":[171,334],"this":[172,206,335],"analysis.":[173],"Results":[174,333],"104":[175],"randomized.":[178],"In":[179,212],"population,":[183],"42%":[184],"XmAb5871-treated":[186,239,276,289],"reached":[188],"vs":[193,202,220,231,254],"28.6%":[194],"(p=0.18)":[199],"40.4%":[201],"23.1%":[203],"(p=0.06)":[204],"achieving":[205],"ITT":[210,267],"population.":[211,268],"those":[213],"no":[216,317,321],"(0%)":[217],"9":[221],"(30%)":[222],"had":[224],"7":[227,232,309],"3":[229],"(13%)":[230],"(23%)":[233],"developing":[234],"scores.":[237],"Six":[238],"infusion-related":[244,293],"events.":[245],"population":[249],"reasons,":[259],"increasing":[260],"response":[262],"proportions":[263],"compared":[264,327],"Time":[269],"significantly":[273],"longer":[274],"than":[278],"(p=0.025,":[280],"see":[281],"figure":[282],"1).":[283],"most":[285],"common":[286],"AEs":[287],"transient,":[292],"gastrointestinal":[294],"side":[295],"effects":[296],"during":[297],"1":[299],"st":[300],"2nd":[302],"infusion.":[303],"There":[304],"8":[306],"SAEs":[307],"XmAb-treated":[310],"subjects,":[311],"5":[312],"patients,":[316],"opportunistic":[318],"infections,":[319],"deaths.":[322],"Infection":[323],"rate":[324],"low":[326],"trials.":[331],"Conclusions":[332],"trial,":[337],"maximize":[340],"interpretability,":[341],"supports":[342],"further":[343],"evaluation":[344],"SLE.":[348],"Funding":[349],"Source(s):":[350],"funded":[354],"Xencor":[356],"Inc.":[357]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2019-04-25T00:00:00"}